HPV is a leading cause of cervical cancer in women, but 50% of people who develop the cancer are never tested. A self-collection test could help.

Aotearoa New Zealand has embraced self-tests for cervical screening with a University of Otago–Ōtākou Whakaihu Waka-led study ...

The test, one of the first of its kind, is designed to reach patients who may forgo traditional screening because of lack of ...

The company has also partnered with the Tata Institute for Genetics and Society (TIGS) to develop an Indigenous HPV PCR kit, further enhancing early detection capabilities ...

Trust chairperson Kiran Dodeja said that 28 girls trained in Beauty Culture received self-employment kits in February, 2024 after completing their course, followed by another 62 in September, 2024.

The self-collection solution, developed in collaboration with Roche and approved for use with Roche’s cobas® HPV test, is designed to provide a discreet and accessible screening option for women, ...

The new offering utilizes the FDA-cleared HPV self-collection solution from Roche (SIX: RO, ROG; OTCQX: RHHBY), approved for use with Roche's cobas® HPV test in May 2024.

The new offering utilizes the FDA-cleared HPV self-collection solution from Roche (RHHBY), approved for use with Roche's cobas HPV test in May 2024. Interested patients can opt for self-collection ...

In 2024, the FDA approved self-collection tests for cervical cancer screenings. Labcorp will also offer a vaginal swab self-collect option for STI testing, including chlamydia, gonorrhea ...

The self-collection solution, developed in collaboration with Roche and approved for use with Roche’s cobas® HPV test, is designed to provide a discreet and accessible screening option for ...

Providers in the United States may now order the FDA-cleared HPV self-collection solution for their patients to use in their offices or other healthcare settings, with goal to reduce barriers to ...